RESPONSE – Partnership for Innovation in Implant Technology

 as part of the BMBF programme "Zwanzig20 – Partnership for Innovation"

Project duration: since 01.11.2015

Partners in the Consortium:  University Rostock/University Medicine/Institute for Biomedical Engineering (Consortium leader), in total 13 partners from scientific institutions and 12 industrial partners

Within the RESPONSE consortium INNOVENT is involved in six different research projects, three of which have already been successfully completed:

Basic Project 2: "Basic developments for technology, biomaterial and active substance innovations"

Project duration: 01.11.2015 – 31.10.2018

Joint project, Funding reference number: 03ZZ0903H

Research Project 5: "Next generation drug delivery system: patient safety and new fields of application for controlled drug release, interaction with materials and tissues"

Subproject 4: "Material development for hydrogel und fiber based DDS"

Project duration: 01.10.2016 – 30.09.2019

Joint project, Funding reference number: 03ZZ0910D

Research Project 9: "Control of the implant-tissue interaction of inner ear implants: New technologies to improve hearing quality and long-term effectiveness"

Project duration: 01.07.2017 – 30.06.2020

Subcontract within the framework of the joint project (Partner: IBMT Rostock)

Research Project 17: "Multifunctional coatings and hierarchically structured materials for adaptive implants"

Subproject 6: "Adaptive implants - technology development for stimulus-responsive nonwoven materials containing active ingredients"

Project duration: 01.01.2019 – 31.12.2021

Joint project, Funding reference number: 03ZZ0927F

Investment project: "RESPONSE - Investment"

Subproject INNOVENT: "Process analytical laboratory for processing and analysis of hyaluronan-based biomaterials"

Project duration: 01.07.2019 – 31.12.2019

Joint project, Funding reference number: 03ZZ09X02

Transfer project 3: "Smart biomaterials for next generation implants"

Subproject 4: "Target oriented biocomposites and biogel networks"

Project duration: 01.01.2020 – 31.12.2021

Joint project, Funding reference number: 03ZZ0933D

RESPONSE aims to develop new, clinically relevant therapies with innovative implants, which will lead to a significant improvement in the chances of cure in the treatment of widespread diseases, especially patients with multimorbid diseases and at the same time reduce the health care system load. The focus is primarily on the cardiovascular, eye and ear areas, where novel implants, implant coatings and drug delivery systems (DDS) are being developed.

Within the RESPONSE consortium, INNOVENT is currently working on hydrogel-forming materials based on functionalized hyaluronan derivatives, electrospinnable (bio-)polymers, the integration of active agents for glaucoma therapy in stimulus-responsive hydrogel and fiber-based systems and innovative antibacterial coatings for cochlear implants.

Response presentation BMBF: https://www.unternehmen-region.de/de/7667.php

Response website: http://www.response.uni-rostock.de/